Corgi Beauty, Skincare & Aesthetics ETF
GLAM - ETF AI Analysis
Top Page
Corgi Beauty, Skincare & Aesthetics ETF (GLAM)
GLAM, the Corgi Beauty, Skincare & Aesthetics ETF, has a solid overall rating driven mainly by strong, well-positioned beauty and healthcare names like Ulta Beauty and AbbVie, which benefit from healthy financial performance, positive earnings outlooks, and strategic growth initiatives. However, weaker holdings such as Bath & Body Works, with revenue and leverage challenges, and companies facing profitability or valuation concerns slightly weigh on the fund’s quality, and investors should note the risk that many holdings share issues like high leverage or stretched valuations within the beauty and consumer health space.
GLAM vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.50M
- Region
- Global
- Expense Ratio
- 0.35%
- Beta
- 0.28
- Issuer
- Corgi
- Inception Date
- May 06, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
GLAM Summary
GLAM is the Corgi Beauty, Skincare & Aesthetics ETF, an actively managed fund focused on the global beauty and personal care theme rather than a traditional index. It invests in companies that make skincare, makeup, hair products, fragrances, packaging, and medical-aesthetic treatments. Well-known holdings include Colgate-Palmolive and Estée Lauder. Someone might invest in GLAM to get growth-oriented, diversified exposure to the beauty and personal care industry, which can benefit from long-term trends like aging populations and rising incomes. A key risk is that it’s concentrated in one sector, so its price can swing more than a broad market fund.
How much will it cost me?
This ETF has an expense ratio of 0.35%, which means you’ll pay about $3.50 per year for every $1,000 you invest. That’s higher than the cost of a typical broad, passively managed index ETF because this is an actively managed, specialized fund focused on the beauty and personal care sector.
What would affect this ETF?
This ETF could benefit if global consumer spending on beauty and personal care keeps growing, especially as aging populations, higher incomes, and online shopping support demand for brands like Colgate-Palmolive, Estée Lauder, and Ulta Beauty, while medical-aesthetics names such as AbbVie and Align gain from increased interest in cosmetic treatments. On the downside, it is heavily focused on health care and consumer staples, so tighter health regulations, changes in drug or cosmetic approvals, weaker consumer confidence, or higher interest rates that hurt growth stocks and global markets could weigh on its performance.
GLAM Top 10 Holdings
GLAM leans heavily on a few beauty powerhouses, with AbbVie acting as the main engine thanks to its rising performance and steady cash generation on the medical-aesthetics side. Colgate-Palmolive and International Flavors & Fragrances add a more traditional consumer staples backbone, both trending higher and helping smooth out volatility. On the pure beauty front, e.l.f. Beauty is a standout riser, while Estée Lauder and Ulta look more mixed, hinting at pockets of weakness in prestige and retail. Overall, it’s a globally focused, beauty-and-health blend, but clearly concentrated in consumer defensive and healthcare names.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| AbbVie | 15.17% | $233.03K | $521.50B | 27.01% | 66Neutral | |
| Colgate-Palmolive | 7.59% | $116.62K | $79.23B | 26.50% | 63Neutral | |
| The Estée Lauder Companies | 6.07% | $93.23K | $40.49B | 24.28% | 56Neutral | |
| Ulta Beauty | 5.75% | $88.32K | $28.25B | 23.75% | 78Outperform | |
| e.l.f. Beauty | 5.55% | $85.29K | $6.98B | 58.60% | 68Neutral | |
| International Flavors & Fragrances | 4.89% | $75.21K | $20.32B | 20.36% | 61Neutral | |
| AptarGroup | 4.38% | $67.25K | $9.07B | 19.04% | 60Neutral | |
| Coty | 4.03% | $61.92K | $3.56B | 11.29% | 49Neutral | |
| Kimberly Clark | 3.83% | $58.91K | $67.15B | 4.77% | 63Neutral |
GLAM Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GLAM, the sentiment is Positive. The current price of 30.41 is above the 20-day moving average (MA) of 30.21, above the 50-day MA of 29.04, and compared to the 200-day MA of , indicating a neutral trend. The MACD of 0.43 indicates Positive momentum. The RSI at 55.60 is Neutral, neither overbought nor oversold. The STOCH value of 40.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GLAM.
GLAM Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $30.41 | $32.00(5.24% Upside) | $1.50M | 0.35% | 62Neutral | |
| $31.35 | $38.00(21.23% Upside) | $94.32M | 0.98% | 65Neutral | |
| $50.33 | $64.35(27.87% Upside) | $81.09M | 0.50% | 70Neutral | |
| $87.79 | $134.22(52.88% Upside) | $72.24M | 0.50% | 69Neutral | |
| $21.17 | $33.21(56.85% Upside) | $60.88M | 0.99% | 60Neutral | |
| $27.45 | $32.42(18.09% Upside) | $816.20K | 0.35% | 62Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GLAM | Corgi Beauty, Skincare & Aesthetics ETF | 30.41 | 4.55 | 17.59% | |
| FFND | Future Fund Active ETF | 31.35 | 2.05 | 7.01% | |
| FDCF | Fidelity Disruptive Communications ETF | 50.33 | 4.24 | 9.19% | |
| IQM | Franklin Intelligent Machines ETF | 87.79 | 2.89 | 3.40% | |
| METL | Sprott Active Metals & Miners ETF | 21.17 | -0.11 | -0.49% | |
| BREW | Corgi Coffee & Energy Drinks ETF | 27.45 | 1.94 | 7.59% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
